Molecular characterization of breast cancer cell lines by a low-density microarray

International Journal of Oncology

Volumn 27, Issue 4, 2005, Pages 881-892

  De Longueville, Francoise ^a   Lacroix, Marc ^b   Barbuto, Anna Maria ^c   Bertholet, Vincent ^a   Gallo, Dominique ^b   Larsimont, Denis ^c   Marcq, Laurence ^a   Zammatteo, Nathalie ^a   Boffe, Sophie ^a   Leclercq, Guy ^b   Remacle, Jose ^d  

^a Eppendorf Array Technologies   (Belgium)

^b University of Bruxelles   (Belgium)

^c JULES BORDET INSTITUTE   (Belgium)

^d UNIVERSITY OF NAMUR   (Belgium)

Author keywords

Breast cancer; Breast cell lines (BCC lines); Low density array

Indexed keywords

COMPLEMENTARY DNA; ESTROGEN RECEPTOR ALPHA; MAMMAGLOBIN; MESSENGER RNA; RNA; TUMOR PROTEIN; UTEROGLOBIN;

ARTICLE; BIOTINYLATION; BREAST TUMOR; CELL ADHESION; CELL PROLIFERATION; CLUSTER ANALYSIS; DNA MICROARRAY; GENE EXPRESSION REGULATION; GENETICS; HUMAN; IMAGE PROCESSING; IMMUNOHISTOCHEMISTRY; METABOLISM; NORTHERN BLOTTING; NUCLEIC ACID HYBRIDIZATION; PATHOLOGY; PHENOTYPE; POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TIME; TUMOR CELL LINE; WESTERN BLOTTING;

BIOTINYLATION; BLOTTING, NORTHERN; BLOTTING, WESTERN; BREAST NEOPLASMS; CELL ADHESION; CELL LINE, TUMOR; CELL PROLIFERATION; CLUSTER ANALYSIS; DNA, COMPLEMENTARY; ESTROGEN RECEPTOR ALPHA; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; IMMUNOHISTOCHEMISTRY; NEOPLASM PROTEINS; NUCLEIC ACID HYBRIDIZATION; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PHENOTYPE; POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA; RNA, MESSENGER; TIME FACTORS; UTEROGLOBIN;

EID: 33644821190     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.27.4.881     Document Type: Article

References (45)

1. Liu ET: Classification of cancers by expression profiling. Curr Opin Genet Dev 13: 97-103, 2003.
2. Lacroix M and Leclercq G: Relevance of breast cancer cell lines as models for breast tumours: an update. Breast Cancer Res Treat 83: 249-289, 2004.
3. Cooper C: Applications of microarray technology in breast cancer research. Breast Cancer Res 3: 158-175,2001.
4. Ross DT and Perou CM: A comparison of gene expression signatures from breast tumors and breast tissue derived cell lines. Dis Markers 17: 99-109, 2001.
5. Bertucci F, Viens P, Hingamp P, Nasser V, Houlgatte R and Birnbaum D: Breast cancer revisited using DNA array-based gene expression profiling. Int J Cancer 103: 565-571, 2003.
6. Ross DT, Scherf U, Eisen MB, Perou CM, Rees C, Spellman P, Iyer V, Jeffrey SS, van de Rijn M, Waltham M, Pergamenschikov A, Lee JC, Lashkari D, Shalon D, Myers TG, Weinstein JN, Botstein D and Brown PO: Systematic variation in gene expression patterns in human cancer cell lines. Nat Genet 24: 227-235, 2000.
7. Lacroix M, Zammatteo N, Remade J and Leclercq G: A lowdensity DNA microarray for analysis of markers in breast cancer. Int J Biol Markers 17: 5-23, 2002.
8. De Longueville F, Surry D, Meneses-Lorente G, Bertholet V, Talbot V, Evrard S, Chandelier N, Pike A, Worboys P, Rasson JP, Le Bourdelles B and Remade J: Gene expression profiling of drug metabolism and toxicology markers using a low-density DNA microarray. Biochem Pharmacol 64: 137-149, 2002.
9. Hamels S, Gala JL, Dufour S, Vannuffel P, Zammatteo N and Remade J: Consensus PCR and microarray for diagnosis of the genus Staphylococcus, species and methicillin resistance. Biotechniques 31: 1364-1366, 1368, 1370-1372,2001.
10. Zammatteo N, Lockman L, Brasseur F, De Plaen E, Lurquin C, Lobert PE, Hamels S, Boon T and Remade J: DNA microarray to monitor the expression of MAGE-A genes. Clin Chem 48: 25-34, 2002.
11. Borras M, Lacroix M, Legros N and Leclercq G: Estrogen receptor-negative/progesterone receptor-positive Evsa-T mammary tumor cells: a model for assessing the biological property of this peculiar phenotype of breast cancers. Cancer Lett 120: 23-30, 1997.
12. Lacroix M, Siwek B, Marie PJ and Body JJ: Production and regulation of interleukin-11 by breast cancer cells. Cancer Lett 127: 29-35, 1998.
13. Lacroix M, Marie PJ and Body JJ: Protein production by osteoblasts: modulation by breast cancer cell-derived factors. Breast Cancer Res Treat 61: 59-67, 2000.
14. Siwek B, Larsimont D, Lacroix M and Body JJ: Establishment and characterization of three new breast-cancer cell lines. Int J Cancer 76: 677-683, 1998.
15. Lee MV, Fong EM, Singer FR and Guenette RS: Bisphosphonate treatment inhibits the growth of prostate cancer cells. Cancer Res 61: 2602-2608, 2001.
16. De Longueville F, Atienzar FA, Marcq L, Dufrane S, Evrard S, Wouters L, Leroux F, Bertholet V, Gerin B, Whomsley R, Arnould T, Remade J and Canning M: Use of a low-density microarray for studying gene expression pattern induced by hepatotoxicants on primary cultures of rat hepatocytes. Toxicol Sci 75: 378-392, 2003.
17. Schuchhardt J, Beule D, Malik A, Wolski E, Eickhoff H, Lehrach H and Herzel H: Normalization strategies for cDNA microarrays. Nucleic Acids Res 28: E47, 2000.
18. Chen Y, Dougherty ER and Bittner ML: Ratio-based decisions and the quantitative analysis of cDNA microarray images. J Biomed Optics 2: 364-374, 1997.
19. Van Cutsem B: Classification and dissimilarity analysis. In: Lecture Notes in Statistics. Springer-Verlag (ed). 1994.
20. Lacroix M, Querton G, Hennebert P, Larsimont D and Leclercq G: Estrogen receptor analysis in primary breast tumors by ligandbinding assay, immunocytochemical assay and northern blot: a comparison. Breast Cancer Res Treat 67: 263-271, 2001.
21. Rivas A, Lacroix M, Olea-Serrano F, Laios I, Leclercq G and Olea N: Estrogenic effect of a series of bisphenol analogues on gene and protein expression in MCF-7 breast cancer cells. J Steroid Biochem Mol Biol 82: 45-53, 2002.
22. Journe F, Body JJ, Leclercq G, Nonclercq D and Laurent G: Estrogen responsiveness of IBEP-2, a new human cell line derived from breast carcinoma. Breast Cancer Res Treat 86: 39-53, 2004.
23. Sommers CL, Byers SW, Thompson EW, Torri JA and Gelmann EP: Differentiation state and invasiveness of human breast cancer cell lines. Breast Cancer Res Treat 31: 325-335, 1994.
24. Watson MA and Fleming TP: Mammaglobin, a mammary-specific member of the uteroglobin gene family, is over-expressed in human breast cancer. Cancer Res 56: 860-865, 1996.
25. Murphy LC, Tsuyuki D, Myal Y and Shiu RP: Isolation and sequencing of a cDNA clone for a prolactin-inducible protein (PIP). Regulation of PIP gene expression in the human breast cancer cell line, T-47D. J Biol Chem 262: 15236-15241, 1987.
26. Dowsett M and Ashworth A: New biology of the oestrogen receptor. Lancet 362: 260-262, 2003.
27. Perou CM, Jeffrey SS, van de Rijn M, Rees CA, Eisen MB, Ross DT, Pergamenschikov A, Williams CF, Zhu SX, Lee JC, Lashkari D, Shalon D, Brown PO and Botstein D: Distinctive gene expression patterns in human mammary epithelial cells and breast cancers. Proc Natl Acad Sci USA 96: 9212-9217, 1999.
28. Jarvinen TA, Tanner M, Rantanen V, Barlund M, Borg A, Grenman S and Isola J: Amplification and deletion of topoisomerase Ilalpha associate with ErbB-2 amplification and affect sensitivity to topoisomerase II inhibitor doxorubicin in breast cancer. Am J Pathol 156: 839-847, 2000.
29. Kauraniemi P, Barlund M, Monni O and Kallioniemi A: New amplified and highly expressed genes discovered in the ERBB2 amplicon in breast cancer by cDNA microarrays. Cancer Res 61:8235-8240,2001.
30. Campbell DH, De Fazio A, Sutherland RL and Daly RJ: Expression and tyrosine phosphorylation of EMS1 in human breast cancer cell lines. Int J Cancer 68: 485-492, 1996.
31. Culty M, Shizari M, Thompson EW and Underhill CB: Binding and degradation of hyaluronan by human breast cancer cell lines expressing different forms of CD44: correlation with invasive potential. J Cell Physiol 160: 275-286, 1994.
32. Pishvaian MJ, Feltes CM, Thompson P, Bussemakers MJ, Schalken JA and Byers SW: Cadherin-11 is expressed in invasive breast cancer cell lines. Cancer Res 59: 947-952, 1999.
33. Bachmeier BE, Nerlich AG, Lichtinghagen R and Sommerhoff CP: Matrix metalloproteinases (MMPs) in breast cancer cell lines of different tumorigenicity. Anticancer Res 21: 3821-3828,2001.
34. Balduyck M, Zerimech F, Gouyer V, Lemaire R, Hemon B, Grard G, Thiebaut C, Lemaire V, Dacquembronne E, Duhem T, Lebrun A, Dejonghe MJ and Huet G: Specific expression of matrix metalloproteinases 1, 3, 9 and 13 associated with invasiveness of breast cancer cells in vitro. Clin Exp Metastasis 18:171-178,2000.
35. Giambernardi TA, Grant GM, Taylor GP, Hay RJ, Maher VM, McCormick JJ and Klebe RJ: Overview of matrix metalloproteinase expression in cultured human cells. Matrix Biol 16: 483-496, 1998.
36. Holst-Hansen C, Johannessen B, Hoyer-Hansen G, Romer J, Ellis V and Brunner N: Urokinase-type plasminogen activation in three human breast cancer cell lines correlates with their in vitro invasiveness. Clin Exp Metastasis 14: 297-307, 1996.
37. Mangel WF, Toledo DL, Nardulli AM, Reiner GC, Norman MJ and Katzenellenbogen BS: Plasminogen activators in human breast cancer cell lines: hormonal regulation and properties. J Steroid Biochem 30: 79-88, 1988.
38. Nunez-Villar MJ, Martinez-Arribas F, Pollan M, Lucas AR, Sanchez J, Tejerina A and Schneider J: Elevated mammaglobin (h-MAM) expression in breast cancer is associated with clinical and biological features defining a less aggressive tumour phenotype. Breast Cancer Res 5: R65-R70, 2003.
39. Jones C, Damiani S, Wells D, Chaggar R, Lakhani SR and Eusebi V: Molecular cytogenetic comparison of apocrine hyperplasia and apocrine carcinoma of the breast. Am J Pathol 158: 207-214,2001.
40. Myal Y, Iwasiow B, Cosby H, Yarmill A, Blanchard A, Tsuyuki D, Fresnoza A, Duckworth ML and Shiu RP: Analysis of tissue- and hormone-specific regulation of the human prolactininducible protein/gross cystic disease fluid protein-15 gene in transgenic mice. J Mol Endocrinol 21: 217-223, 1998.
41. Ormandy CJ, Clarke CL, Kelly PA and Sutherland RL: Androgen regulation of prolactin-receptor gene expression in MCF-7 and MDA-MB-453 human breast cancer cells. Int J Cancer 50: 777-782, 1992.
42. Peirce SK and Chen WY: Quantification of prolactin receptor mRNA in multiple human tissues and cancer cell lines by realtime RT-PCR. J Endocrinol 171: R1-R4, 2001
43. Hall RE, Birrell SN, Tilley WD and Sutherland RL: MDAMB- 453, an androgen-responsive human breast carcinoma cell line with high level androgen receptor expression. Eur J Cancer 30A: 484-490, 1994.
44. Yuen T, Zhang W, Ebersole BJ and Sealfon SC: Monitoring G-protein-coupled receptor signaling with DNA microarrays and real-time polymerase chain reaction. Methods Enzymol 345: 556-569, 2002.
45. Gerhold D, Lu M, Xu J, Austin C, Caskey CT and Rushmore T: Monitoring expression of genes involved in drug metabolism and toxicology using DNA microarrays. Physiol Genomics 5: 161-170,2001.